What non-EU manufacturers need to know about EU Regulatory Requirements
Care robotics is rapidly evolving from an emerging technology into a commercially viable component of modern healthcare and elderly care. Driven by demographic change, workforce shortages and increasing demand for care services, healthcare providers are exploring a wide range of robotic solutions, from mobility assistance and patient monitoring to AI-enabled interaction systems.
For manufacturers, however, technical innovation is only one part of the equation. Companies seeking access to the European market must navigate an increasingly complex regulatory landscape. Depending on their intended purpose, functionality and deployment scenario, care robots may be subject to multiple layers of EU regulation.
A key consideration is whether a robotic system qualifies as a medical device under the Medical Device Regulation (MDR). If so, manufacturers must comply with extensive requirements relating to risk management, technical documentation, clinical evaluation and conformity assessment before placing the product on the European market.
Even where a system falls outside the scope of the MDR, other regulatory frameworks may apply. Connected robotic systems frequently constitute products with digital elements and may therefore be subject to the Cyber Resilience Act (CRA), which introduces mandatory cybersecurity requirements throughout the product lifecycle. In addition, the Machinery Regulation may become relevant for robotic systems.
Artificial intelligence adds a further layer of complexity. Many care robots rely on AI-driven functions such as environmental perception, behavioural analysis, autonomous navigation or human-machine interaction. Depending on the specific use case, these functionalities may trigger obligations under the EU AI Act. Manufacturers should therefore assess at an early stage whether their systems qualify as high-risk AI systems and whether additional requirements concerning risk management, transparency, data governance, human oversight and post-market monitoring apply.
Although the primary obligations under these regulations are imposed on manufacturers and other economic operators, healthcare providers and care facilities increasingly incorporate legal and compliance requirements into their procurement processes. As a result, non-EU manufacturers are frequently asked to demonstrate compliance with European cybersecurity, AI, Data Protection and other regulatory requirements. Regulatory compliance is therefore becoming a competitive factor as well as a legal necessity.
Care robotics offers significant opportunities for innovation in healthcare and elderly care. Manufacturers that integrate regulatory requirements into product design, development and market access strategies at an early stage will be better positioned to reduce legal risks, meet customer expectations and successfully access the European market.
back